Chips & deep tech ยท Article
Samsung Biologics Goes Pure CDMO as Celltrion Signs 400 Billion Won Production Deal
๋น์ฆ์์น ยท

At a glance
Samsung Biologics split off its biosimilar business and now focuses purely on contract manufacturing, which has changed alliances in the bio industry. Celltrion, a long-time rival, signed a contract worth over 400 billion won with Samsung Biologics for drug production.
Key points
- Samsung Biologics spun off its biosimilar business and now focuses on contract development and manufacturing (CDMO).
- Celltrion agreed to have Samsung Biologics produce drugs worth more than 400 billion won.
- The split removed the link between a rival company and a manufacturing partner, which made cooperation possible.
- Drug developers handle development and sales while CDMOs handle production, similar to the chip industry's fabless and foundry model.
Why it matters
It shows that rival drugmakers can now cooperate by splitting development and production roles, which could change how the bio industry competes.
Original source
๋ฐ๋์ฒด ์ ๊ณ์ฒ๋ผโฆ๋ฐ์ด์ค ํ๋ '์์ CDMO'๊ฐ ๋ฐ๊ฟจ๋ค
๋น์ฆ์์น ยท Nov 20, 07:40 KST
Read on ๋น์ฆ์์น โAI summarized the original article. Check the original for accuracy. Copyright belongs to ๋น์ฆ์์น.
More from this field
- Intel Lands First Outside Customer for 18A Chip Manufacturing Process
Intel said it has signed its first outside customer for its 18A manufacturing process, a sign that other companies are starting to trust its chip-making service. The company's CEO said the first contract covers a process he was personally involved in. Microsoft was also named as the first official customer for Intel's EMIB advanced packaging technology.
์ฐํฉ๋ด์ค ยท Nov 20, 08:08 KST - Samsung and TSMC Pause Some Chip Shipments to China as US Tightens Export Rules
Samsung Electronics and TSMC have reportedly stopped shipping some chips to Chinese customers while they wait for US approval. The move follows new US export rules meant to slow China's AI development. The Financial Times reported the story, citing people familiar with the matter.
ํ์ด๋ธ์ ๋ด์ค ยท Nov 20, 07:25 KST - Micron Plans $10 Billion Boise Research Lab as AI Raises Memory R&D Stakes
Micron Technology is building Micron Research Labs in Boise, Idaho, with a planned $10 billion investment over the next decade. The lab will look past the next chip generation and focus on future memory and manufacturing research. Groundbreaking is expected in 2027.
EE Times ยท Nov 20, 07:21 KST